DEPOMED INC's ticker is and the CUSIP is 249908AA2. A total of 42 filers reported holding DEPOMED INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,681,000 | -47.2% | 2,400,000 | -38.0% | 0.06% | -32.6% |
Q2 2018 | $3,183,000 | +0.6% | 3,871,000 | 0.0% | 0.09% | -14.0% |
Q1 2018 | $3,165,000 | -2.8% | 3,871,000 | 0.0% | 0.11% | -2.7% |
Q4 2017 | $3,257,000 | +30.5% | 3,871,000 | +14.8% | 0.11% | +23.6% |
Q3 2017 | $2,495,000 | -16.0% | 3,371,000 | 0.0% | 0.09% | -19.8% |
Q2 2017 | $2,969,000 | -6.2% | 3,371,000 | 0.0% | 0.11% | -8.3% |
Q1 2017 | $3,165,000 | -18.2% | 3,371,000 | 0.0% | 0.12% | -16.6% |
Q4 2016 | $3,867,000 | -19.8% | 3,371,000 | -0.1% | 0.14% | -15.2% |
Q3 2016 | $4,820,000 | +16.3% | 3,373,000 | -1.6% | 0.17% | +14.0% |
Q2 2016 | $4,143,000 | +29.2% | 3,429,000 | 0.0% | 0.15% | +42.9% |
Q1 2016 | $3,206,000 | -16.7% | 3,429,000 | +1.7% | 0.10% | -16.0% |
Q4 2015 | $3,847,000 | -19.3% | 3,371,000 | -15.7% | 0.12% | -10.7% |
Q3 2015 | $4,766,000 | -7.4% | 4,000,000 | 0.0% | 0.14% | +6.9% |
Q2 2015 | $5,149,000 | – | 4,000,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 4,500,000 | $3,964,000 | 2.82% |
Telemetry Investments, L.L.C. | 5,000,000 | $4,388,000 | 2.06% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 23,500,000 | $20,904,000 | 1.92% |
CQS Cayman LP | 17,000,000 | $15,174,000 | 1.04% |
Sonora Investment Management, LLC | 5,275,000 | $4,639,890,000 | 0.88% |
LINDEN ADVISORS LP | 19,150,000 | $16,881,000 | 0.71% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 47,500,000 | $41,919,000,000 | 0.69% |
MACKAY SHIELDS LLC | 14,016,000 | $12,344,000 | 0.52% |
ADVENT CAPITAL MANAGEMENT /DE/ | 27,933,000 | $24,614,000 | 0.47% |
Senvest Management, LLC | 5,000,000 | $4,419,000 | 0.35% |